CA2236598A1 - Traitement de la cardiomyopathie par elimination des auto-anticorps - Google Patents

Traitement de la cardiomyopathie par elimination des auto-anticorps

Info

Publication number
CA2236598A1
CA2236598A1 CA002236598A CA2236598A CA2236598A1 CA 2236598 A1 CA2236598 A1 CA 2236598A1 CA 002236598 A CA002236598 A CA 002236598A CA 2236598 A CA2236598 A CA 2236598A CA 2236598 A1 CA2236598 A1 CA 2236598A1
Authority
CA
Canada
Prior art keywords
patient
column
treatment
immunoapheresis
pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002236598A
Other languages
English (en)
Other versions
CA2236598C (fr
Inventor
Stephan Felix
Petra Reinke
Stefan Brehme
Gert Baumann
Robert Koll
Jutta Muller-Derlich
Reiner Spaethe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edwards Lifesciences Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US1996/018457 external-priority patent/WO1997017980A1/fr
Publication of CA2236598A1 publication Critical patent/CA2236598A1/fr
Application granted granted Critical
Publication of CA2236598C publication Critical patent/CA2236598C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • External Artificial Organs (AREA)
CA002236598A 1995-11-15 1996-11-15 Traitement de la cardiomyopathie par elimination des auto-anticorps Expired - Lifetime CA2236598C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55926295A 1995-11-15 1995-11-15
US08/559,262 1995-11-15
PCT/US1996/018457 WO1997017980A1 (fr) 1995-11-15 1996-11-15 Traitement de la cardiomyopathie par elimination des auto-anticorps

Publications (2)

Publication Number Publication Date
CA2236598A1 true CA2236598A1 (fr) 1997-05-22
CA2236598C CA2236598C (fr) 2006-09-12

Family

ID=36999314

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002236598A Expired - Lifetime CA2236598C (fr) 1995-11-15 1996-11-15 Traitement de la cardiomyopathie par elimination des auto-anticorps

Country Status (1)

Country Link
CA (1) CA2236598C (fr)

Also Published As

Publication number Publication date
CA2236598C (fr) 2006-09-12

Similar Documents

Publication Publication Date Title
ATE266415T1 (de) Behandlung von dilatierte kardiomyopathie durch entfernung von autoantikoerpern
CA2235372A1 (fr) Procede de traitement des tissus ischemies
FI963759A0 (fi) Metalloseeniyhdisteitä, menetelmä niiden valmistamiseksi ja niiden käyttö olefiinien polymerointiin tarkoitetuissa katalyyteissä
CA2107556A1 (fr) Augmentation de la permeabilite de la barriere hemato-encephalique a l'aide de peptides permeabilisants
IT1202652B (it) Processo per la preparazione di 1,1,1-trifluoro-2,2-dicloroetano mediante idrofluorurazione in presenza di catalizzatori
EP0890642A3 (fr) Rétrovirus du groupe HIV et son application
WO1997017446A3 (fr) ANTICORPS HUMANISES DIRIGES CONTRE LA gp39 D'ORIGINE HUMAINE, COMPOSITIONS CONTENANT CES ANTICORPS ET LEUR UTILISATION THERAPEUTIQUE
EP0871726A4 (fr) Recepteurs chimeres a specificites multiples
DE69220946T2 (de) Verwendung von nukleinsäureanaloga in diagnostischen und analytischen verfahren
WO2001012659A3 (fr) Sequence d'adn humain
AU4090697A (en) Improved process for preparing the antiviral agent {1s-(1alpha, 3alpha, 4beta)}-2-amino-1,9-dihydro-9-{4-hydroxy-3-(hydroxymethyl)-2 -methylenecyclopentyl}-6h-purin-6-one
EP1082433A4 (fr) Interleukine 21 et 22
US4440675A (en) Human immune interferon
CA2229028A1 (fr) Molecules d'acides nucleiques, proteine et peptides associes aux cellules du colon et aux cellules cancereuses du colon
CA2299504A1 (fr) Anticorps diriges contre des epitopes specifiques a l'oxydation sur lipoproteines et leurs procedes d'utilisation dans la detection, le suivi et l'inhibition de la croissance d'atheromes
EE200000627A (et) Inimese BMP-7 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudja neeruhaiguste raviks ettenähtud aine uurimiseks
IT1276155B1 (it) Catalizzatori per l'ossiclorurazione dell'etilene,procedimento per la loro preparazione e procedimento di ossiclorurazione impiegante gli
CA2236598A1 (fr) Traitement de la cardiomyopathie par elimination des auto-anticorps
AU6572596A (en) Method of recovering immunoglobulin from fractions produced during fractionation of human blood plasma
ITBO930059A0 (it) Procedimento per ottenere la rigenerazione dei tessuti nella terapia odontoiatrica parodentale.
WO1997003701A3 (fr) Composes et methodes de traitement de cancers lies au recepteur egf et purification du recepteur egf
WO1998018822A3 (fr) Nouvelles proteines humaines lim
DE3786673D1 (de) Verfahren zur entfernung unerwuenschter zellen aus menschlichen lymphozytenpopulationen, anwendung des verfahrens zur herstellung monoklonaler antikoerper und dafuer geeigneter kit.
WO1998018942A3 (fr) Nouvelles proteines humaines rab
WO2002101394A3 (fr) Procede de criblage a l'aide des proteines bnpi et dnpi

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20161115